Status:

COMPLETED

Trough Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol

Lead Sponsor:

University of Dundee

Conditions:

Asthma

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The objective of this study is to compare the relative bronchoprotection (at trough) conferred by 2-week chronic dosing with levosalbutamol and racemic salbutamol in mild to moderate asthmatics. Patie...

Eligibility Criteria

Inclusion

  • Mild to moderate stable asthmatics on ≤ 2000μg BDP or equivalent, who are methacholine responsive PC20\< 4 mg/ml
  • \>1dd change in methacholine PC20 after the administration of racemic Salbutamol.
  • Male or female 18-65
  • Informed Consent
  • Ability to comply with the requirements of the protocol

Exclusion

  • Severe asthmatics as defined by an FEV1≤ 60% or PEF variability \> 30% or with continual daytime or nocturnal symptoms.
  • The use of oral corticosteroids within the last 3 months.
  • Recent respiratory tract infection (2 months).
  • Significant concomitant respiratory disease such as COPD, CF, ABPA, bronchiectasis and active pulmonary tuberculosis.
  • Any other clinically significant medical condition such as unstable angina, acute myocardial infarction in the preceding 3 months, recent TIA/ CVA, that may endanger the health or safety of the participant, or jeopardise the protocol.
  • Any significant abnormal laboratory result as deemed by the investigators
  • Pregnancy, planned pregnancy or lactation
  • Known or suspected contra-indication to any of the IMP's
  • Concomitant use of medicines (prescribed, over the counter or herbal) that may interfere with the trial.

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2012

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00831376

Start Date

January 1 2009

End Date

April 1 2012

Last Update

April 12 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Asthma and Allergy Research Group

Dundee, Angus, United Kingdom, DD1 9SY